Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 6
Submit an article Journal homepage
898
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran

Shahrokh IzadiHealth Promotion Research Centre, School of Public Health, Zahedan University of Medical Sciences, Zahedan, IranCorrespondence[email protected]
View further author information
,
Seyed Mohsen ZahraeiCentre for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, IranView further author information
&
Talat Mokhtari-AzadNational Reference Laboratory for Measles and Rubella, School of Public Health, Tehran University of Medical Sciences, Tehran, IranView further author information
Pages 1412-1416 | Received 13 Nov 2017, Accepted 30 Jan 2018, Published online: 26 Feb 2018

References

  • Personnaz D, Larson H. Iran and Turkey launch world's largest measles campaigns Geneva: Unicef; 2003; updated 9 December 2003 [accessed 2016 October 04]. http://www.unicef.org/media/media_18172.html.
  • Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J. 2007;26(12):1137–41. doi:10.1097/INF.0b013e3181462090. PMID:18043452.
  • Izadi S, Zahraie SM, Sartipi M. An investigation into a measles outbreak in southeast Iran. Jpn J Infect Dis. 2012;65(1):45–51. PMID:22274157.
  • Karimi A, Arjomandi A, Alborzi A, Rasouli M, Kadivar MR, Obood B, Pourabbas B. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran. East Mediterr Health J. 2004;10(4-5):468–73. PMID:16335636.
  • Immunization, Vaccination and Biologicals; Measles and Rubella Surveillance Data. World Health Organization; 2017; updated 11 September 2017 [accessed 2017 September 29]. http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/.
  • Karami M, Zahraei SM, Sabouri A, Soltanshahi R, Biderafsh A, Piri N, Lee JK. Documentation of measles elimination in Iran: Evidences from 2012 to 2014. J Res Health Sci. 2017;17(3):e00387. PMID:28878113.
  • World Health Organization. Progress towards measles elimination in Bangladesh, 2000–2016. Wkly Epidemiol Rec. 2017;92(30):405–16. PMID:28737029.
  • World Health Organization. Measles vaccines: WHO position paper – April 2017. Wkly Epidemiol Rec. 2017;92(17):205–28.
  • Izadi S, Mokhtari-Azad T, Zahraei SM. Measles vaccination coverage and seroprevalence of anti-measles antibody in south-east Islamic Republic of Iran. East Mediterr Health J. 2015;21(6):396–402. doi:10.26719/2015.21.6.396. PMID:26369998.
  • Pannuti CS, Morello RJ, de Moraes JC, Curti SP, Afonso AM, Camargo MC, Souza VA. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 são paulo epidemic. Clin Diagn Lab Immunol. 2004;11(1):119–22. PMID:14715557.
  • Paunio M, Hedman K, Davidkin I, Peltola H. IGG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy. Expert Opin Pharmacother. 2003;4(8):1215–25.. doi:10.1517/14656566.4.8.1215. PMID:12877632.
  • Thompson KM. Evolution and use of dynamic transmission models for measles and rubella risk and policy analysis. Risk Anal. 2016;36(7):1383–403. doi:10.1111/risa.12637. PMID:27277138.
  • Halloran ME, Longini IM, Struchiner CJ. Design and Analysis of Vaccine Studies. London: Springer; 2010.
  • World Health Organization. Rubella Vaccine: WHO position paper. Wkly Epidemiol Rec. 2011;86(29):301–16. PMID:21766537.
  • Sadighi J, Eftekhar H, Mohammad K. Congenital rubella syndrome in Iran. BMC Infect Dis. 2005;5:44. doi:10.1186/1471-2334-5-44. PMID:15938744.
  • Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q. 1991;44(3):98–106. PMID:1949887.
  • Statistical Centre of Iran; Census 2016 – General Results I.R.Iran: Iranian Statistical Centre; 2016; Results and tables of the last Population and Housing Census in the I.R.Iran, performed on 2016. [accessed 2017 November 16] https://www.amar.org.ir/english/Population-and-Housing-Censuses/Census-2016-General-Results.
  • Izadi S, Naieni KH, Madjdzadeh SR, Nadim A. Crimean-Congo haemorrhagic fever in Sistan and Baluchestan province of Iran, a case-control study on epidemiological characteristics. Int J Infect Dis. 2004;8(5):299–306. doi:10.1016/j.ijid.2003.10.008. PMID:15325599.
  • Zahraei SM, Izadi S, Mokhtari-Azad T. Factors affecting the seroconversion rate of 12-month-old babies after the first injection of measles vaccine in the southeast of Iran. Hum Vaccin Immunother. 2016;12(12):3118–24. doi:10.1080/21645515.2016.1214346.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.